Here are six points:
1. The two joined forces to co-market the ME1000 Surgical Impactor.
2. They will begin co-marketing the technology this quarter.
3. The ME1000 Surgical Impactor is intended for total hip arthroplasty.
4. The technology produces constant, table energy that helps automate bone preparation, implant assembly and positioning.
5. Due to the automation component, the technology may lead to less surgeon fatigue and work-related injures from mallet use.
6. DePuy Synthes emphasizes the ME1000 Surgical Impactor is only compatible with DePuy Synthes hip systems.
More articles on devices:
Bioventus names new CFO, general counsel: 4 takeaways
Mazor Robotics, K2M, Globus Medical & more: 12 device company notes
SeaSpine reports $34.2M in Q2 revenue: 6 things to know
